Accéder au contenu
Merck
Toutes les photos(2)

Key Documents

View All Documentation

C7464

Sigma-Aldrich

Monoclonal Anti-Cyclin D1 antibody produced in mouse

clone DCS-6, ascites fluid

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Numéro MDL:
MFCD00239664
Code UNSPSC :
12352203
Nomenclature NACRES :
NA.41

Source biologique

mouse

Niveau de qualité

200

Conjugué

unconjugated

Forme d'anticorps

ascites fluid

Type de produit anticorps

primary antibodies

Clone

DCS-6, monoclonal

Poids mol.

antigen 36 kDa (several lower and higher molecular weight bands)

Contient

15 mM sodium azide

Espèces réactives

rat, mouse, human, monkey

Technique(s)

immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
immunohistochemistry (frozen sections): suitable
immunoprecipitation (IP): suitable
microarray: suitable
western blot: 1:200 using a human tumor cell line extract

Isotype

IgG2a

Numéro d'accès UniProt

P24385

Conditions d'expédition

dry ice

Température de stockage

−20°C

Modification post-traductionnelle de la cible

unmodified

Informations sur le gène

human ... CCND1(595)
mouse ... Ccnd1(12443)
rat ... Ccnd1(58919)

Description générale

Monoclonal Anti-Cyclin D1 (mouse IgG2a isotype) is derived from the DCS-6 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from an immunized mouse. Cyclin D1 protein is a G1-phase cyclin in mammalian cells. This protein is a D-type cyclin. The CCD1 gene is located on the human chromosome at 11q13.3.

Spécificité

Does not cross-react with other D-type cyclins.

Immunogène

recombinant human Cyclin D1 protein.

Application

Monoclonal Anti-Cyclin D1 antibody produced in mouse may be used in:
  • immunoblotting
  • immunofluorescence
  • immunocytochemistry
  • immunoprecipitation
  • immunohistochemistry
  • antibody-mediated knock-out experiments

Actions biochimiques/physiologiques

Cyclin D1 is involved in regulating cyclin-dependent kinase (CDK) family members. Cyclin D1 and D2 are affiliated with CDK4 and/or CDK6 kinase activities that are observed in mid-G1 and culminate in the late G1 phase. Amplification of the cyclin D1 gene is observed in a significant percentage of cancers, including breast, bladder carcinoma, mantle cell lymphomas, head and neck cancers. This gene is also amplified in esophageal squamous cell carcinomas.

Forme physique

The product is provided as ascites fluid with 15 mM sodium azide as a preservative.

Stockage et stabilité

For continuous use, store at 2-8 °C for up to one month. For extended storage, the solution may be frozen in working aliquots. Repeated freezing and thawing is not recommended. Storage in "frost-free" freezers not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use.

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Vous ne trouvez pas le bon produit ?  

Essayez notre Outil de sélection de produits.

En option

Réf. du produit
Description
Tarif

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

H Nakagawa et al.
Cancer, 76(4), 541-549 (1995-08-15)
Oncogene activation and tumor suppressor gene inactivation have been implicated in the genetic basis of esophageal squamous cell carcinoma (ESCC). Cyclin D1, an oncogene that has a critical role in G1 progression of the cell cycle, has been observed to
Takeshi Shimamura et al.
Cancer research, 65(14), 6401-6408 (2005-07-19)
Somatic mutations in the kinase domain of the epidermal growth factor receptor (EGFR), including L858R and exon 19 deletions, underlie responsiveness to gefitinib and erlotinib in non-small cell lung cancer (NSCLC). Acquired resistance to these tyrosine kinase inhibitors is in
Mu Yao et al.
The British journal of nutrition, 108(3), 424-430 (2011-11-10)
We have developed a blend of food extracts commonly consumed in the Mediterranean and East Asia, named blueberry punch (BBP), with the ultimate aim to formulate a chemoprevention strategy to inhibit prostate cancer progression in men on active surveillance protocol.
Mu Yao et al.
Oncotarget, 6(33), 34458-34474 (2015-09-30)
Cell cycle re-entry of quiescent cancer cells has been proposed to be involved in cancer progression and recurrence. Cytosolic phospholipase A2α (cPLA2α) is an enzyme that hydrolyzes membrane glycerophospholipids to release arachidonic acid and lysophospholipids that are implicated in cancer
S John Weroha et al.
Carcinogenesis, 27(3), 491-498 (2005-11-29)
A common feature of human breast oncogenesis is cell cycle deregulation. The expression of cyclins D1 and D3 was examined during estradiol-17beta (E(2))-induced mammary tumorigenesis in female August Copenhagen Irish (ACI) rats. Low serum E(2) levels ( approximately 60-120 pg/ml)
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique